# EDGAR Filing Document

**Accession Number:** 0001737995
**File Stem:** 0001641172-25-025267
**Filing Date:** 2025-8
**Character Count:** 51669
**Document Hash:** de37892ed76bd5409cf6bd2d59566329
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-025267.hdr.sgml**: 20250822

**ACCESSION NUMBER**: 0001641172-25-025267

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 16

**FILED AS OF DATE**: 20250822

**DATE AS OF CHANGE**: 20250822

**EFFECTIVENESS DATE**: 20250822

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sharps Technology Inc.
- **CENTRAL INDEX KEY:** 0001737995
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 823751728
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-289820
- **FILM NUMBER:** 251247233

**BUSINESS ADDRESS:**
- **STREET 1:** 105 MAXESS ROAD
- **STREET 2:** STE. 124
- **CITY:** MELVILLE
- **STATE:** NY
- **ZIP:** 11747
- **BUSINESS PHONE:** (631) 574 -4436

**MAIL ADDRESS:**
- **STREET 1:** 105 MAXESS ROAD
- **STREET 2:** STE. 124
- **CITY:** MELVILLE
- **STATE:** NY
- **ZIP:** 11747

As filed with the Securities and Exchange Commission on August 22, 2025

Registration No. 333-

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM S-8**

**REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933**

---

| |
|:---|
| **SHARPS TECHNOLOGY, INC.** |
| (Exact name of registrant as specified in its charter) |

---

---

| | |
|:---|:---|
| **Nevada** | **82-3751728** |
| (State or other jurisdiction of<br> incorporation or organization) | (I.R.S. Employer<br> Identification No.) |

---

---

| |
|:---|
| **105 Maxess Road, Suite 124, Melville, NY** |
| (Address of Principal Executive Offices, including zip code) |

---

---

| |
|:---|
| **2025 EQUITY INCENTIVE PLAN** |
| (Full title of the plan) |

---

---

| | |
|:---|:---|
| **Paul K. Danner**<br> **Executive Chairman**<br> **Sharps Technology, Inc.**<br> **105 Maxess Road, Ste. 124**<br> **Melville, New York 11747**<br> **(631) 574 -4436**<br>(Name, address and telephone number, including area code,<br> of agent for service) | *Copy to:*<br> **Arthur Marcus, Esq.**<br> **Jesse L. Blue, Esq.**<br> **Sichenzia Ross Ference Carmel LLP**<br> **1185 Avenue of the Americas, 31<sup>st</sup> Floor**<br> **New York, NY 10036**<br> **(212) 930-970** |

---

Indicate by check mark whether the Company is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer", "small reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one)

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☒

**EXPLANATORY NOTE**

This Registration Statement on Form S-8 (this "Registration Statement") is filed by Sharps Technology, Inc., a Nevada corporation (the "Registrant"), to register 2,000,000 of the Registrant's common shares, par value $0.0001 per share, for issuance under the Company's 2025 Equity Incentive Plan.

P**ART I**

**INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS**

**Item 1. Plan Information.**

Not required to be filed with this Registration Statement.

**Item 2. Registrant Information and Employee Plan Annual Information.**

Not required to be filed with this Registration Statement.

**PART II**

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT**

**Item 3. Incorporation of Documents by Reference.**

We are "incorporating by reference" in this Prospectus certain documents we file with the SEC, which means that we can disclose important information to you by referring you to those documents. The information in the documents incorporated by reference is considered to be part of this Prospectus. Statements contained in documents that we file with the SEC and that are incorporated by reference in this Prospectus will automatically update and supersede information contained in this Prospectus, including information in previously filed documents or reports that have been incorporated by reference in this Prospectus, to the extent the new information differs from or is inconsistent with the old information. We incorporate by reference the following information or documents that we have filed with the SEC (excluding those portions of any Form 8-K that are not deemed "filed" pursuant to the General Instructions of Form 8-K):

● our
 Annual Report on [Form 10-K](https://www.sec.gov/Archives/edgar/data/1737995/000164117225000989/form10-k.htm) for the fiscal year ended December 31, 2024, filed with the SEC on March 27, 2025; the Amendment to our
 Annual Report on [Form 10-K/A](https://www.sec.gov/Archives/edgar/data/1737995/000164117225004905/form10-ka.htm) for the fiscal year ended December 31, 2025, filed with the SEC on April 15, 2025;

● our
 Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025, and June 30, 2025, filed with the SEC on [May 15, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000164117225010894/form10-q.htm) and [August 13, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000164117225023597/form10-q.htm) , respectively;

● our
 Current Reports on Form 8-K filed with the SEC on [January 22, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000149315225003111/form8-k.htm) , [January 30, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000149315225004282/form8-k.htm) , [March 14, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000149315225010375/form8-k.htm) , [March 20, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000149315225010990/form8-k.htm) , [March 28, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000164117225001083/form8-k.htm) , [April 2, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000164117225002359/form8-k.htm) , [April 3, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000164117225002559/form8-k.htm) , [April 4, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000164117225002801/form8-k.htm) , [April 14, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000164117225004600/form8-k.htm) , [April 18, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000164117225005465/form8-k.htm) , [April 25, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000164117225006045/form8-k.htm) , [April 30, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000164117225007892/form8-k.htm) / [April 30, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000164117225006796/form8-k.htm) , [May 6, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000164117225008754/form8-k.htm) , [May 7, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000164117225008966/form8-k.htm) , [May 22, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000164117225012002/form8-k.htm) , [June 4, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000164117225013536/form8-k.htm) , [July 3, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000164117225017827/form8-k.htm) and [July 18, 2025](https://www.sec.gov/Archives/edgar/data/1737995/000164117225020215/form8-k.htm) ;

● our [Form 8-A12B](https://www.sec.gov/Archives/edgar/data/1737995/000149315222009678/form8-a12b.htm) , filed with the SEC on April 12, 2022, including any subsequent amendments or reports filed for the purpose of updating
 such description.

Any information in any of the foregoing documents will automatically be deemed to be modified or superseded to the extent that information in this Prospectus supplement or the accompanying prospectus or in a later filed document that is incorporated or deemed to be incorporated herein by reference modifies or replaces such information.

We also incorporate by reference any future filings (excluding information furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items) made with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, until we sell all of the securities offered by this Prospectus supplement. Information in such future filings updates and supplements the information provided in this Prospectus supplement. Any statements in any such future filings will automatically be deemed to modify and supersede any information in any document we previously filed with the SEC that is incorporated or deemed to be incorporated herein by reference to the extent that statements in the later filed document modify or replace such earlier statements.

We will provide, without charge, to each person, including any beneficial owner, to whom a copy of this Prospectus is delivered, upon written or oral request of such person, a copy of any or all of the documents incorporated by reference in this Prospectus, other than exhibits to such documents unless such exhibits are specifically incorporated by reference into such documents. Requests may be made by contacting:

**Sharps Technology, Inc.**

**105 Maxess Road, Ste. 124**

**Melville, New York 11747**

**(631) 574 -4436**

**Item 4. Description of Securities.**

Not applicable.

**Item 5. Interests of Named Experts and Counsel.**

Not applicable.

**Item 6. Indemnification of Directors and Officers.**

The Nevada Revised Statutes (the "NRS") empower us to indemnify our directors and officers against expenses relating to certain actions, suits or proceedings as provided for therein. In order for such indemnification to be available, the applicable director or officer must not have acted in a manner that constituted a breach of his or her fiduciary duties and involved intentional misconduct, fraud or a knowing violation of law, or must have acted in good faith and reasonably believed that his or her conduct was in, or not opposed to, our best interests. In the event of a criminal action, the applicable director or officer must not have had reasonable cause to believe his or her conduct was unlawful.

Pursuant to our Articles, we may indemnify each of our present and future directors, officers, employees or agents who becomes a party or is threatened to be made a party to any suit or proceeding, whether pending, completed or merely threatened, and whether said suit or proceeding is civil, criminal, administrative, investigative, or otherwise, except an action by or in the right of the Company, by reason of the fact that he is or was a director, officer, employee, or agent of the Company, or is or was serving at the request of the corporation as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, or other enterprise, against expenses, including, but not limited to, attorneys' fees, judgments, fines, and amounts paid in settlement actually and reasonably incurred by him in connection with the action, suit, proceeding or settlement, provided such person acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interest of the Company, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful.

The expenses of directors, officers, employees or agents of the Company incurred in defending a civil or criminal action, suit, or proceeding may be paid by the Company as they are incurred and in advance of the final disposition of the action, suit, or proceeding, if and only if the director, officer, employee or agent undertakes to repay said expenses to the Company if it is ultimately determined by a court of competent jurisdiction, after exhaustion of all appeals therefrom, that he/she is not entitled to be indemnified by the Company.

No indemnification shall be applied, and any advancement of expenses to or on behalf of any director, officer, employee or agent must be returned to the Company, if a final adjudication establishes that the person's acts or omissions involved a breach of any fiduciary duties, where applicable, intentional misconduct, fraud or a knowing violation of the law which was material to the cause of action.

The NRS further provides that a corporation may purchase and maintain insurance or make other financial arrangements on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise for any liability asserted against him and liability and expenses incurred by him in his capacity as a director, officer, employee or agent, or arising out of his status as such, whether or not the corporation has the authority to indemnify him/her against such liability and expenses. We have secured a directors' and officers' liability insurance policy. We expect that we will continue to maintain such a policy.

**Disclosure of Commission Position on Indemnification for Securities Act Liabilities**

Insofar as indemnification for liabilities under the Securities Act may be permitted to officers, directors or persons controlling the Company pursuant to the foregoing provisions, the Company has been informed that is it is the opinion of the SEC that such indemnification is against public policy as expressed in such Securities Act and is, therefore, unenforceable.

**Item 7. Exemption From Registration Claimed.**

The grant of our securities were issued as compensation awards or as enticement or incentive awards. These grants were exempt from registration pursuant to Section 4(2) of the Securities Act.

**Item 8. Exhibits.**

---

| | |
|:---|:---|
| **Exhibit**<br> **Number** | **Description** |
| 1.1 | [Form of Underwriting Agreement (incorporated by reference to Exhibit 1.1 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex1-1.htm) |
| 3.1 | [Articles of Incorporation of Registrant (incorporated by reference to Exhibit 3.1 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex3-1.htm) |
| 3.2 | [Certificate of Designation of Series A Preferred Stock (incorporated by reference to Exhibit 3.2 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex3-2.htm) |
| 3.3 | [Certificate of Amendment to Designation, filed on December 28, 2022 (incorporated by reference to 8-K filed on December 28, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222036665/ex3-1.htm) |
| 3.4 | [Bylaws of Registrant (incorporated by reference to Exhibit 3.3 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex3-3.htm) |
| 3.5 | [Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 of the Registrants Registration Statement on Form S-1; No. 333-284237, originally filed with the Securities and Exchange Commission on January 22, 2025)](https://www.sec.gov/Archives/edgar/data/1737995/000149315225003225/ex3-1.htm) |
| 5.1 | [Opinion of Sichenzia Ross Ference Carmel LLP](ex5-1.htm) |
| 10.1 | [Asset/Share Purchase Agreement, dated June 10, 2020, among the Company, Safegard Medical (Hungary) Ktf, Numan Holding Ltd, Cortrus Services SA and Latitude Investments Limited (incorporated by reference to Exhibit 10.1 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-1.htm) |
| 10.2 | [Amendment No. 1 to Asset/Share Purchase Agreement, dated June 24, 2020 (incorporated by reference to Exhibit 10.2 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-2.htm) |
| 10.3 | [Amendment No. 2 to Asset/Share Purchase Agreement, dated August 27, 2020 (incorporated by reference to Exhibit 10.3 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-3.htm) |
| 10.4 | [Amendment No. 3 to Asset/Share Purchase Agreement, dated October 28, 2020 (incorporated by reference to Exhibit 10.4 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-4.htm) |
| 10.5 | [Amendment No. 4 to Asset/Share Purchase Agreement, dated July 19, 2021 (incorporated by reference to Exhibit 10.5 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-5.htm) |
| 10.6 | [Amendment No. 5 to Asset/Share Purchase Agreement, dated February 28, 2022 (incorporated by reference to Exhibit 10.6 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-6.htm) |
| 10.7 | [Letter, dated September 23, 2021, from Numan Holding Ltd (incorporated by reference to Exhibit 10.7 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-7.htm) |
| 10.8 | [Employment Agreement, dated September 9, 2021, between the Company and Robert Hayes (incorporated by reference to Exhibit 10.8 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-8.htm) |
| 10.9 | [Consulting Agreement between the Company and Alan Blackman (incorporated by reference to Exhibit 10.9 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-9.htm) |

---

---

| | |
|:---|:---|
| **Exhibit**<br> **Number** | **Description** |
| 10.10 | [Amended Consulting Agreement, dated May 28, 2019, between the Company and Barry Berler (incorporated by reference to Exhibit 10.10 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-10.htm) |
| 10.11 | [Royalty Agreement, dated July 11, 2017, between Alan Blackman and Barry Berler (incorporated by reference to Exhibit 10.11 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-11.htm) |
| 10.12 | [Amendment to Royalty Agreement, dated September 4, 2018 (incorporated by reference to Exhibit 10.12 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-12.htm) |
| 10.13 | [Consulting Agreement, dated January 1, 2021, between the Company and Berry Berler (incorporated by reference to Exhibit 10.13 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-13.htm) |
| 10.14 | [Note Purchase Agreement, dated December 14, 2021, among the Company and the purchasers named therein (incorporated by reference to Exhibit 10.14 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-14.htm) |
| 10.15 | [Form of Note (incorporated by reference to Exhibit 10.15 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-15.htm) |
| 10.16 | [Security Agreement among the Company and the secured parties named therein (incorporated by reference to Exhibit 10.16 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-16.htm) |
| 10.17 | [Consent to be named as a director nominee of Jason Monroe (incorporated by reference to Exhibit 10.17 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-17.htm) |
| 10.18 | [Consent to be named as a director nominee of Brenda Baird Simpson (incorporated by reference to Exhibit 10.18 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-18.htm) |
| 10.19 | [Form of Warrant for this offering (incorporated by reference to Exhibit 10.19 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-19.htm) |
| 10.20 | [Form of Pre-Funded Warrant for this offering (incorporated by reference to Exhibit 10.20 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222008116/ex10-20.htm) |
| 10.21 | [Form of Warrant Agent Agreement (Pre-Funded Warrants) (incorporated by reference to Exhibit 10.21 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222008116/ex10-21.htm) |
| 10.22 | [2022 Equity Incentive Plan (incorporated by reference to Exhibit 10.22 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222008116/ex10-22.htm) |
| 10.23 | [Plan and Agreement of Merger, dated March 22, 2022, between Sharps Technology, Inc., a Wyoming corporation, and Sharps Technology, Inc., a Nevada corporation (incorporated by reference to Exhibit 10.23 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222009164/ex10-23.htm) |
| 10.24 | [Form of Warrant Agent Agreement (Warrants) (incorporated by reference to Exhibit 10.24 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222009164/ex10-24.htm) |
| 10.25 | [Form of Representative's Warrant (incorporated by reference to Exhibit 10.25 of the Registrant's Registration Statement on Form S-1; No. 333-263715, as amended, originally filed with the Securities and Exchange Commission on March 18, 2022)](https://www.sec.gov/Archives/edgar/data/1737995/000149315222009164/ex10-25.htm) |
| 10.26 | [2024 Equity Incentive Plan (incorporated by reference to Exhibit 10.36 of the Registrant's Registration Statement on Form S-1; 333-284237, originally filed on January 22, 2025)](https://www.sec.gov/Archives/edgar/data/1737995/000149315225003225/ex10-36.htm) |
| 23.1\* | [Consent of PKF O'Connor Davies LLP](ex23-1.htm) |
| 99.1\* | [Compensation Recovery Policy](ex99-1.htm) |
| 107 | [Filing Fee Table](ex107.htm) |

---

\* Filed herewith

**Item 9. Undertakings.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The undersigned Company hereby undertakes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To include any prospectus required by section 10(a)(3) of the Securities Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the SEC by the Company pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The undersigned Company hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Company's annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Company pursuant to the foregoing provisions, or otherwise, the Company has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Company of expenses incurred or paid by a director, officer or controlling person of the Company in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Company will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

**SIGNATURES**

Pursuant to the requirements of the Securities Act, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized in Melville, New York, on the 22<sup>nd</sup> of August, 2025.

---

| | |
|:---|:---|
| **SHARPS TECHNOLOGY, INC.** | **SHARPS TECHNOLOGY, INC.** |
| By: | */s/ Robert M. Hayes* |
|  | Robert M. hayes |
|  | Executive Chairman |

---

**POWER OF ATTORNEY**

KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Robert M. Hayes their true and lawful attorneys-in-fact and agent, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments, to this Registration Statement on Form S-8, and to file the same, with exhibits thereto and other documents in connection therewith, with the SEC granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that each of said attorney-in-fact and agent, or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Name** | **Position** | **Date** |
| */s/ Robert M. Hayes* | Chief Executive Officer and Director (Principal Executive Officer) | August 22, 2025 |
| Robert M. Hayes |  |  |
| */s/ Andrew R. Crescenzo* | Chief Financial Officer and Corporate Secretary (Principal Financial and Accounting Officer) | August 22, 2025 |
| Andrew R. Crescenzo |  |  |
| */s/ Paul K. Danner* | Executive Chairman of the Board of Directors | August 22, 2025 |
| Paul K. Danner |  |  |
| */s/ Dr. Soren Bo Christiansen* | Director | August 22, 2025 |
| Dr. Soren Bo Christiansen |  |  |
| */s/ Timothy J. Ruemler* | Director | August 22, 2025 |
| Timothy J. Ruemler |  |  |
| */s/ Brenda Baird Simpson* | Director | August 22, 2025 |
| Brenda Baird Simpson |  |  |
| */s/ Jason L. Monroe* | Director | August 22, 2025 |
| Jason L. Monroe |  |  |

---

## Exhibit 5.1

**Exhibit 5.1**

![](ex5-1_001.jpg)

August 22, 2025

Sharps Technology, Inc.

105 Maxess Road, Suite, 124

Melville, New York 11747

**Re: Sharps Technology, Inc. - Form S-8 Registration Statement**

Ladies and Gentlemen:

We refer to the above-captioned registration statement on Form S-8 (the "Registration Statement") under the Securities Act of 1933, as amended (the "Act"), filed by Sharps Technology, Inc., a Nevada corporation (the "Company"), with the Securities and Exchange Commission (the "Commission").

We have examined the originals, photocopies, certified copies or other evidence of such records of the Company, certificates of officers of the Company and public officials, and other documents as we have deemed relevant and necessary as a basis for the opinion hereinafter expressed. In such examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as certified copies or photocopies and the authenticity of the originals of such latter documents.

Based on our examination mentioned above, we are of the opinion that the securities being issued pursuant to the Registration Statement, when so issued, are legally and validly issued fully paid and non-assessable.

We hereby consent to the filing of this opinion as Exhibit 5.1 to the Registration Statement. In giving the foregoing consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Act, or the rules and regulations of the Commission.

---

| |
|:---|
| Very truly yours, |
| */s/ Sichenzia Ross Ference Carmel LLP* |
| Sichenzia Ross Ference Carmel LLP |

---

1185 AVENUE OF THE AMERICAS \| 31ST FLOOR \| NEW YORK, NY \| 10036

T (212) 930-9700 \| F (212) 930-9725 \| WWW.SRFC.LAW

## Exhibit 23.1

**Exhibit 23.1**

**Consent of Independent Registered Public Accounting Firm**

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 filed under the Securities Act of 1933, as amended, of our report dated March 27, 2025, relating to the consolidated financial statements of Sharps Technology Inc. appearing in the Annual Report on Form 10-K as of and for the year ended December 31, 2024.

*/s/ PKF O'Connor Davies, LLP*

August 22, 2025

New York, New York

\* \* \* \* \*

## Exhibit 99.1

**Exhibit 99.1**

**SHARPS TECHNOLOGY, INC.**

**COMPENSATION RECOVERY POLICY**

Effective April 15, 2025

In accordance with Section 10D of the Securities Exchange Act of 1934, as amended (the "**Exchange Act**"), Exchange Act Rule 10D-1, the listing rule of the Nasdaq Capital Market (the "**Exchange**") where the securities of Sharps Technology, Inc. (the "**Company**") are listed, the Company's Board of Directors (the "**Board**") has adopted this Compensation Recovery Policy (the "**Policy**"). The purpose of this Policy is to recover the erroneously awarded Inventive-Based Compensation (defined below), if any, in the event that the Company is required to prepare an Accounting Restatement.

Capitalized terms used in the Policy are defined in <u>Section A</u> below. The application of the Policy to Executive Officers is not discretionary, except to the limited extent provided in <u>Section G</u> below, and applies without regard to whether an Executive Officer was at fault.

**A.** **Definitions** 

"**Accounting Restatement**" means an accounting restatement due to the material noncompliance of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.

"**Accounting Restatement Determination Date**" means the date that a Company is required to prepare an Accounting Restatement, which is the earlier of: (a) the date the Board, a committee of the Board, or one or more of the officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement; and (b) the date a court, regulator, or other legally authorized body directs the Company to prepare an Accounting Restatement.

"**Excess Compensation**" means the amount of Incentive-Based Compensation Received that exceeds the amount of Incentive-Based Compensation that otherwise would have been Received had such Incentive-Based Compensation been determined based on the restated amounts (this is referred to in the listings standards as "erroneously awarded incentive-based compensation") and must be computed without regard to any taxes paid.

"**Executive Officer**" means each individual who is or was ever designated as an "officer" by the Board in accordance with Exchange Act Rule 16a-1(f).

"**Financial Reporting Measures**" means measures that are determined and presented in accordance with the accounting principles used in preparing the Company's financial statements, and any measures that are derived wholly or in part from such measures. Stock price and total shareholder return are also Financial Reporting Measures. A Financial Reporting Measure need not be presented within the financial statements or included in a filing with the Securities and Exchange Commission.

"**Incentive-Based Compensation**" means any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a Financial Reporting Measure (for the avoidance of doubt, no compensation that is potentially subject to recovery under the Policy will be earned until the Company's duty to recover under the Policy has lapsed) and excludes the following: salaries, bonuses paid solely at the discretion of the Committee or Board that are not paid from a bonus pool that is determined by satisfying a Financial Reporting Measure, bonuses paid solely upon satisfying one or more subjective standards and/or completion of a specified employment period, non-equity incentive plan awards earned solely upon satisfying one or more strategic measures or operational measures, and equity awards for which the grant is not contingent upon achieving any Financial Reporting Measure performance goal and vesting upfront, upon the signing of certain agreements, or is contingent solely upon completion of time requirement (e.g., time-based vesting equity awards) and/or attaining one or more non-Financial Reporting Measures.

"**Received**" means, with respect to any Incentive-based Compensation, actual or deemed receipt, and Incentive-Based Compensation is "Received" under the Policy in the Company's fiscal period during which the Financial Reporting Measure specified in the Incentive-Based Compensation award is attained, even if the payment or grant of the Incentive-Based Compensation occurs after the end of that period. For the avoidance of doubt, the Policy does not apply to Incentive-Based Compensation for which the Financial Reporting Measure is attained prior to December 31, 2024.

**B.** **Persons Covered by the Policy** 

The Policy is binding and enforceable against all Executive Officers who received Incentive-Based Compensation covered by this Policy from the Company (See <u>Section E</u> below).

**C.** **Administration of the Policy** 

The Compensation Committee of the Board (the "**Committee**") has full-delegated authority to administer the Policy. The Committee is authorized to interpret and construe the Policy and to make all determinations necessary, appropriate, or advisable for the administration of the Policy. In addition, if determined in the discretion of the Board, the Policy may be administered by the independent members of the Board or another committee of the Board made up of independent members of the Board, in which case all references to the Committee will be deemed to refer to such independent members of the Board or such other Board committee. All determinations of the Committee will be final and binding and will be given the maximum deference permitted by law.

**D.** **Accounting Restatements Requiring Application of the Policy** 

If the Company is required to prepare an Accounting Restatement, then the Committee must determine the Excess Compensation, if any, that must be recovered. The Company's obligation to recover Excess Compensation is not dependent on if or when the restated financial statements are filed.

**E.** **Compensation Covered by the Policy** 

The Policy applies to all Incentive-Based Compensation Received by an Executive Officer:

&nbsp;&nbsp;&nbsp;&nbsp;(a) after
 beginning service as an Executive Officer;

&nbsp;&nbsp;&nbsp;&nbsp;(b) who
 served as an Executive Officer at any time during the performance period for that Incentive-Based Compensation;

&nbsp;&nbsp;&nbsp;&nbsp;(c) while
 the Company has a class of securities listed on the Exchange;

&nbsp;&nbsp;&nbsp;&nbsp;(d) during
 the three completed fiscal years immediately preceding the Accounting Restatement Determination Date. In addition to these last three
 completed fiscal years, the Policy must apply to any transition period (that results from a change in the Company's fiscal
 year) within or immediately following those three completed fiscal years. However, a transition period between the last day of the
 Company's previous fiscal year end and the first day of the Company's new fiscal year that comprises a period of nine
 to 12 months would be deemed a completed fiscal year; and

&nbsp;&nbsp;&nbsp;&nbsp;(e) on
 or after December 31, 2024.

**F.** **Excess Compensation Subject to Recovery of the Policy** 

To determine the amount of Excess Compensation for Incentive-Based Compensation based on stock price or total shareholder return, where it is not subject to mathematical recalculation directly from the information in an Accounting Restatement, the amount must be based on a reasonable estimate of the effect of the Accounting Restatement on the stock price or total shareholder return upon which the Incentive-Based Compensation was Received and the Company must maintain documentation of the determination of that reasonable estimate and provide the documentation to the Exchange.

**G.** **Repayment of Excess Compensation** 

The Company must recover Excess Compensation reasonably promptly and Executive Officers are required to repay Excess Compensation to the Company. Subject to applicable law, the Company may recover Excess Compensation by requiring the Executive Officer to repay such amount to the Company by direct payment to the Company or such other means or combination of means as the Committee determines to be appropriate (these determinations do not need to be identical as to each Executive Officer). These means may include:

&nbsp;&nbsp;&nbsp;&nbsp;(a) requiring
 reimbursement of cash Incentive-Based Compensation previously paid;

&nbsp;&nbsp;&nbsp;&nbsp;(b) seeking
 recovery of any gain realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based awards;

&nbsp;&nbsp;&nbsp;&nbsp;(c) offsetting
 the amount to be recovered from any unpaid or future compensation to be paid by the Company or any affiliate of the Company to the
 Executive Officer;

&nbsp;&nbsp;&nbsp;&nbsp;(d) cancelling
 outstanding vested or unvested equity awards; and/or

&nbsp;&nbsp;&nbsp;&nbsp;(e) taking
 any other remedial and recovery action permitted by law, as determined by the Committee.

The repayment of Excess Compensation must be made by an Executive Officer notwithstanding any Executive Officer's belief (whether or not legitimate) that the Excess Compensation had been previously earned under applicable law and therefore is not subject to recovery.

The Company is prohibited from indemnifying any Executive Officer or former Executive Officer against the loss of Excess Compensation.

In addition to its rights to recovery under the Policy, the Company or any affiliate of the Company may take any legal actions it determines appropriate to enforce an Executive Officer's obligations to the Company or its affiliate or to discipline an Executive Officer, including (without limitation) termination of employment, institution of civil proceedings, reporting of misconduct to appropriate governmental authorities, reduction of future compensation opportunities, or change in role. The decision to take any actions described in the preceding sentence will not be subject to the approval of the Committee and can be made by the Board, any committee of the Board, or any duly authorized officer of the Company or of any applicable affiliate of the Company.

**H.** **Limited Exceptions to the Policy** 

The Company must recover Excess Compensation in accordance with the Policy except to the limited extent that any of the conditions set forth below are met, and the Committee determines that recovery of the Excess Compensation would be impracticable:

&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 direct expense paid to a third party to assist in enforcing the Policy would exceed the amount to be recovered. Before reaching this
 conclusion, the Company must make a reasonable attempt to recover the Excess Compensation, document the reasonable attempt(s) taken
 to so recover, and provide that documentation to the Exchange;

&nbsp;&nbsp;&nbsp;&nbsp;(b) Recovery
 would violate home country law where that law was adopted prior to December 31, 2024. Before reaching this conclusion, the Company
 must obtain an opinion of home country counsel, acceptable to the Exchange, that recovery would result in such a violation, and must
 provide such opinion to the Exchange; or

&nbsp;&nbsp;&nbsp;&nbsp;(c) Recovery
 would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company,
 to fail to meet the requirements of 26 U.S.C. 401(a)(13) (Assignment and alienation) or 26 U.S.C. 411(a) (Minimum vesting standards)
 and regulations thereunder.

&nbsp;&nbsp;&nbsp;&nbsp;**I.** **Other Important Information in the Policy** 

Notwithstanding the terms of any of the Company's organizational documents (including, but not limited to, the Company's bylaws), any corporate policy or any contract (including, but not limited to, any indemnification agreement), neither the Company nor any affiliate of the Company will indemnify or provide advancement for any Executive Officer against any loss of Excess Compensation, or any claims relating to the Company's enforcement of its rights under the Policy. Neither the Company nor any affiliate of the Company will pay for or reimburse insurance premiums for an insurance policy that covers potential recovery obligations. In the event that pursuant to the Policy the Company is required to recover Excess Compensation from an Executive Officer who is no longer an employee, the Company will be entitled to seek recovery in order to comply with applicable law, regardless of the terms of any release of claims or separation agreement such individual may have signed. Neither the Company nor any affiliate of the Company will enter into any agreement that exempts any Incentive-Based Compensation that is granted, paid, or awarded to an Executive Officer from the application of the Policy or that waives the Company's right to recovery of any Excess Compensation, and the Policy shall supersede any such agreement (whether entered into before, on, or after the adoption of the Policy).

The Committee or Board may review and modify the Policy from time to time.

If any provision of the Policy or the application of any such provision to any Executive Officer is adjudicated to be invalid, illegal, or unenforceable in any respect, such invalidity, illegality, or unenforceability will not affect any other provisions of the Policy or the application of such provision to another Executive Officer, and the invalid, illegal or unenforceable provisions will be deemed amended to the minimum extent necessary to render any such provision or application enforceable.

The Policy will terminate and no longer be enforceable when the Company ceases to be a listed issuer within the meaning of Section 10D of the Exchange Act or when the Exchange Act Rule 10D-1, and rules of the Nasdaq Capital Market are no longer effective.

## Ex-Filing

?xml version='1.0' encoding='ASCII'?

**Exhibit 107**

**Calculation of Filing Fee Table**

**FORM S-8**

**REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933**

(Form Type)

**SHARPS TECHNOLOGY, INC.**

(Exact Name of Registrant As Specified in its Charter)

<u>Table 1: Newly Registered Securities</u>

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Security Type** | **Security**<br> **Class Title** | **Fee**<br> **Calculation Rule** | **Amount Registered<sup>(1)</sup>** |  | **Proposed Maximum Offering Price Per Share** |  | **Maximum Aggregate Offering Price** | **Fee Rate** | **Amount of Registration Fee** |
| **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** |
| **Fees to Be Paid** | Equity | Common Shares | 457(c) and (h) | 2000000 | (2) | $6.32 | (3) | 12640000 | $0.00015310 | $1935.184 |
| **Fees Previously Paid** |  |  |  |  |  |  |  |  |  | 0 |
| **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** |  |  |  |  | 12640000 | $- | $1935.184 |
| **Total Fees Previously Paid** | **Total Fees Previously Paid** | **Total Fees Previously Paid** | **Total Fees Previously Paid** |  |  |  |  | $- |  | $- |
| **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** |  |  |  |  |  |  | $- |
| **Net Fees Due** | **Net Fees Due** | **Net Fees Due** | **Net Fees Due** |  |  |  |  | $- |  | $1935.184 |

---

(1) Pursuant to Rule 416(a) promulgated under the U.S. Securities Act of 1933, as amended, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends, or similar transactions.

(2) Represents Common Shares reserved for future issuance under the Company's 2025 Equity Incentive Plan.

(3) Estimated solely for the purpose of calculating the registration fee under Rule 457(c) and (h) of the Securities Act on the basis of the average of the high and low sales price per Common Share on August 21, 2025, as reported on the Nasdaq Capital Market.